发明名称 Prodrugs to D-prolines
摘要 <p>The invention relates to compounds of formulae wherein R 1 and R 2 are independently from each other and signify lower alkoxy, lower alkenyloxy, benzyloxy, hydroxy, €•OCH(CH 3 )OC(O)-lower alkyl or €•OCH 2 C(O)N(R 3 )(R 4 ), with the proviso that only one of R 1 or R 2 may be hydroxy; R 3 and R 4 are independently from each other and signify hydrogen, lower alkyl, lower alkenyl or cycloalkyl; or R 1 and R 2 form together with the carbon atom, to which they are attached the linking group X, wherein X is €•O(CH 2 ) n CH=CH(CH 2 ) n O- or -O(CH 2 ) m O-; n is 1, 2 or 3; and m is 4-8. as well as pharmaceutically acceptable salts of said compounds. Compounds of the present invention can be used for the treatment of diseases where Serum Amyloid P Component depletion has a beneficial effect, in particular in the treatment or prevention of all forms of central and systemic amyloidosis.</p>
申请公布号 EP1743884(A1) 申请公布日期 2007.01.17
申请号 EP20060020711 申请日期 2002.12.06
申请人 F.HOFFMANN-LA ROCHE AG 发明人 HUWYLER, JOERG;JAKOB-ROETNE, ROLAND;POLI, SONIA MARIA
分类号 C07D207/16;A61K31/401;A61K31/407;A61P3/10;A61P25/28;A61P43/00;C07D498/14 主分类号 C07D207/16
代理机构 代理人
主权项
地址